Award
Delivery Order #SPE2DR26FBQAS
Delivery Order for XOLAIR Autoinject from DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$1,747.44
Ceiling
$1,747.44
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Mar 13, 2026
Identifier
SPE2DR26FBQAS
NAICS
424210
This award is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and supply chain management. The order procures XOLAIR 300 MG/2 ML autoinjectors, a critical pharmaceutical product used for healthcare treatments. It supports the agency's ongoing pharmaceutical supply needs, particularly under a broader strategic pharmaceutical supply contract that ensures consistent access to essential medications. The contract scope involves delivering the specified quantities of the autoinjectors within a short timeframe to a designated location in Park Ridge, Illinois. The award follows a prior indefinite delivery vehicle contract for pharmaceutical supplies, indicating continuity in service provision. This delivery order is part of an ongoing multi-year supply effort, reflecting the importance of maintaining timely availability of vital drugs to public health programs. The order was likely awarded through a competitive process under the existing contract vehicle to meet urgent pharmaceutical demands in early 2026.
Description
4570956353!XOLAIR 300 MG/2 ML AUTOINJECT 2ML